Login / Signup

Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.

Joshua D GrillRema RamanKarin ErnstromShunran WangMichael C DonohuePaul S AisenJason KarlawishDavid HenleyGary RomanoGerald NovakH Robert BrashearReisa A Sperling
Published in: Neurology. Clinical practice (2024)
Although sample bias must be considered, these results suggest that amyloid disclosure resulted in increased perceived risk and mild distress in those learning an elevated result. Although this study did not assess psychological safety, observed associations intrusive thoughts and distress could be important considerations in the future clinical practice.
Keyphrases
  • clinical practice
  • cognitive decline
  • depressive symptoms
  • current status
  • mild cognitive impairment
  • sleep quality